Dr Marco Gerlinger
Consultant Medical Oncologist FRCP
Available at: Chelsea
- Colon and Rectal cancer
- Stomach and Oesophageal cancer
- Targeted therapy
- Personalised cancer medicine
Dr Gerlinger is a Consultant Medical Oncologist specializing in the treatment of oesophageal, stomach and bowel cancers at the Royal Marsden Hospital. He leads the Translational Oncogenomics Research Team at the Institute of Cancer Research, London.
Dr Gerlinger studied Medicine at the University of Munich, at Harvard Medical School and at Imperial College London and obtained his research MD from the Institute of Immunology at the University in Munich. He trained in General Medicine and Medical Oncology at the University Hospital Zurich, Switzerland, at University College Hospital, The Royal Marsden Hospital and St Bartholomew’s Hospital in London. He undertook post-doctoral research training in cancer immunotherapy in Zurich and in cancer genomics and biomarker discovery at the Cancer Research UK London Research Institute.
He became a Consultant Medical Oncologist at St Bartholomew’s Hospital in London in 2012. In 2013 he joined The Royal Marsden Hospital as a Consultant in Gastrointestinal Oncology and the Institute of Cancer Research to lead a research group developing new immunotherapies and targeted therapies for drug-resistant cancers. He is developing and leading clinical trials based on research discoveries from his laboratory and other labs worldwide.
His research has been funded by Cancer Research UK, the Medical Research Council and the European Research Council and is published in leading international journals including the New England Journal of Medicine, Nature Genetics and Cancer Cell.